C. R. Bard
136
5
9
101
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 65/100
16.2%
22 terminated/withdrawn out of 136 trials
82.1%
-4.4% vs industry average
12%
16 trials in Phase 3/4
66%
67 of 101 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (136)
Post-market Surveillance Study of the BD® WavelinQ™ EndoAVF System
Role: lead
An Evaluation of the PureWick™ Male External Catheter Versus an Established Comparator Overnight in the Home Setting for Incontinence in Adult Males
Role: lead
Evaluation of Male and Female External Catheters for Urine Output Monitoring in the ICU
Role: lead
The BD Liverty™ TIPS Stent Graft Study
Role: lead
Prophylactic Reinforcement of Ventral Abdominal Incisions Trial
Role: lead
Study of GalaFLEX LITE™ Scaffold in Treatment of Capsular Contracture After Breast Implant Augmentation
Role: lead
Intrapleural Catheter Daily Versus Three Times a Week Drainage
Role: collaborator
Venclose digiRF System Post Market Study
Role: lead
Post Approval Study Investigating Lutonix Drug Coated Balloon for Treatment of Dysfunctional Arteriovenous Fistulae
Role: lead
Observational Study of TissuePatch SF in Prevention of Air Leaks Following Lung Resection
Role: lead
Study of BD Sirolimus Drug Coated Catheter for Treatment of Femoropopliteal Arteries
Role: lead
Effectiveness and Safety of TIPS Stent Graft in the Treatment of Cirrhosis and Complications of Portal Hypertension
Role: lead
Real-World Registry of the Rotarex(TM) Rotational Excisional Atherectomy System (XTRACT Registry)
Role: lead
Post Approval Study of the BARD® COVERA™ Arteriovenous (AV) Stent Graft
Role: lead
Safety and Effectiveness of a New Pleural Catheter for Symptomatic, Recurrent, MPEs Versus Approved Pleural Catheter
Role: lead
everlinQ endoAVF Post Market Study
Role: lead
everlinQ Endovascular Access System Enhancements (EASE) Study
Role: lead
Test for Pre Operative Skin Preparations
Role: lead
everlinQ Endovascular Access Systems Enhancements (EASE-2) Study
Role: lead
Evaluating Safety and Effectiveness of Octenidine Dihydrochloride
Role: lead